Table 3 Continuous outcomes
Outcome | Placebo (n = 40) | NAC + DFX (n = 40) | P value |
|---|---|---|---|
Time to develop AKI, days, median (IR) | 1.5 (1–4.5) | 1 (1–2) | 0.53 |
AKI duration, days, median (IR) | 0.5 (0–6) | 1 (0–2) | 0.04 |
ICU-free days to day 28, median (IR) | 18 (2–23) | 15 (2–23) | 0.68 |
Hospital length of stay, days, median (IR) | 10 (6–22) | 12 (7–18) | 0.58 |
Creatinine level at discharge, mg/dL, median (IR) | 1.1 (0.6–1.8) | 0.7 (0.5–1.2) | 0.05 |
SOFA score day 3, median (IR) | 9 (4–14) | 6.5 (5–10) | 0.28 |
Renal SOFA score day 3, median (IR) | 3 (0–3) | 1 (0–2.2) | 0.10 |